Results and Exploratory Biomarker Analyses of a Phase II Study CHANGEABLE: Combination of HX008 and Niraparib in Germ-Line-mutated Metastatic Breast Cancer.
JOURNAL OF CLINICAL ONCOLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined